Botanix Pharma Talks With FDA on Antibacterial Drug
The Green Fund has published a summary of Botanix Pharmaceutical’s BTX 1801 announcement today, an update on the development pathway for our BTX 1801 antimicrobial product.
Take a look at the article here.
